UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052663
Receipt number R000060062
Scientific Title Verification of the effect of long-term intake of Kamaboko on blood glucose levels.
Date of disclosure of the study information 2023/11/26
Last modified on 2023/10/31 14:16:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of the effect of long-term intake of Kamaboko on blood glucose levels.

Acronym

Verification of the effect of long-term intake of Kamaboko on blood glucose levels.

Scientific Title

Verification of the effect of long-term intake of Kamaboko on blood glucose levels.

Scientific Title:Acronym

Verification of the effect of long-term intake of Kamaboko on blood glucose levels.

Region

Japan


Condition

Condition

Adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Clarify the effects of long-term intake of Kamaboko on human blood glucose levels.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Area under the curve of blood glucose level

Key secondary outcomes

Blood glucose levels, insulin levels, Area under the curve of insulin level


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake of one Kamaboko (45g) per day for 12 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

69 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Persons whose Fasting blood glucose level is 110 mg/dL or more and less than 126 mg/dL in the results of the pre-test.
2.Persons who are judged by the investigator to be able to safely participate in the study based on the results of the pre-test.

Key exclusion criteria

1.Persons receiving treatment or medication for diabetes.
2.Persons who HbA1c 6.5% or higher.
3.Persons undergoing treatment for gastrointestinal diseases.
4.Persons undergoing treatment for cardiovascular disease.
5.Persons undergoing treatment for psychiatric disorders.
6.Pregnant and lactating women.
7.Persons with a history of allergic reactions to seafood, chicken eggs, wheat, or soybeans.
8.Persons who currently participating in another clinical trial or participated in one within the past 3 months.
9.Other persons deemed ineligible by the study investigator.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Natsuka
Middle name
Last name Takada

Organization

Ichimasa Kamaboko Co., Ltd.

Division name

Technical Research Department

Zip code

950-8735

Address

7-77 Tsushimaya,Higashi-ku, Niigata-shi, Niigata, Japan

TEL

025-270-7119

Email

giken2020@ichimasa.co.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Goto

Organization

Niigata Bio-Research Park, Inc

Division name

Business Promotion Department

Zip code

956-0841

Address

316-2 Higashijima,Akiha-ku, Niigata City, Niigata, Japan

TEL

0250-25-1196

Homepage URL


Email

goto@nbrp.co.jp


Sponsor or person

Institute

Niigata Bio-Research Park, Inc

Institute

Department

Personal name



Funding Source

Organization

Ichimasa Kamaboko Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

NBRC Research Ethics Review Committee

Address

316-2 Higashijima,Akiha-ku, Niigata City, Niigata, Japan

Tel

0250-25-1196

Email

nbrp-food-navi@nbrp.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 10 Month 17 Day

Date of IRB


Anticipated trial start date

2023 Year 11 Month 26 Day

Last follow-up date

2024 Year 04 Month 25 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 10 Month 31 Day

Last modified on

2023 Year 10 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060062


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name